Skip to main content
Article
A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.
Leukemia (2008)
  • Z Diaz, McGill University
  • K K Mann, McGill University
  • S Marcoux, McGill University
  • M Kourelis, McGill University
  • M Colombo, McGill University
  • P B Komarnitsky, ZIOPHARM ONCOLOGY INC
  • W H Miller, McGill University
Disciplines
Publication Date
October 1, 2008
DOI
10.1038/leu.2008.194
Citation Information
Z Diaz, K K Mann, S Marcoux, M Kourelis, et al.. "A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines." Leukemia Vol. 22 Iss. 10 (2008) p. 1853 - 1863
Available at: http://works.bepress.com/zuanel-diaz/6/